Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Factors of the Treatment Failure in HCV Mono-infected Patients Treated With Pegylated-interferon/Ribavirin/Telaprevir.

NCT01577069 is registered in ClinicalTrials.gov with Association HGE CHU Bordeaux Sud as lead sponsor.

NCT NCT01577069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01577069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Factors of the Treatment Failure in HCV Mono-infected Patients Treated With Pegylated-interferon/Ribavirin/Telaprevir.
Lead sponsor
Association HGE CHU Bordeaux Sud
Phase
Observational
Overall status
Completed
Start date
February 28, 2011
Completion date
January 31, 2013
Enrollment
73 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c